Browse News
Filter News
Found 549,268 articles
-
Accenture recently published a new report, “New Science: Biopharma’s New Growth Machine.” In it, the report attempts to evaluate the last 20 years of trends in biopharma and use that data to develop projections for the future of the industry.
-
Companies across Europe and Asia provide information about deal, clinical trials and more, with news from Synaptive Medical, Epic, Inventiva, Velabs, and more.
-
Plaque psoriasis is the most common type of psoriasis, caused by overproduction of skin cells. This causes inflamed, red lesions called plaques.
-
For the past nine years, Saynor has been with GSK, most recently serving as senior vice president and global head of classic and established medicines.
-
The government said the executives and the company failed to comply with its legal obligation to report thousands of suspicious orders of controlled substances to the DEA.
-
GenFit’s lead product candidate elafibranor snagged Breakthrough Therapy Designation from the U.S. Food and Drug Administration as a treatment for Primary Biliary Cholangitis (PBC) following strong Phase II results that demonstrated the safety and efficacy of the medication.
-
The life sciences industry has seen significant growth over the past 10 years in Georgia. From 2007 to 2017, employment in the Peach State’s industry sciences grew by 14.9 percent. That growth outpaced the 7.7 percent national growth, Georgia Bio announced.
-
Cambridge, Mass.-based Fulcrum Therapeutics just acquired a worldwide license with GlaxoSmithKline (GSK) to develop and commercialize losmapimod.
-
Researchers at Sweden’s Lund University reported that a blood test can reveal whether there is accelerating nerve cell damage in the brain.
-
One of the criticisms of the biopharma industry—at least in the context of drug pricing—is how much the industry as a whole spends on lobbyists. For example, last year, PhRMA, the industry lobbying group, spent more than $27.5 million on its lobbying activities.
-
Despite a Q1 Drop in Sales, J&J Anticipates New Indications Will Increase Xarelto Revenue Growth
4/24/2019
Life sciences giant blamed the Medicare "doughnut hole" and increased competition for the blood thinner's declining sales. -
ADC Therapeutics, based in Lausanne, Switzerland, and Adagene, headquartered in Suzhou, China and San Francisco, announced a discovery collaboration and license deal.
-
Government of Canada takes further steps to address the opioid crisis in British Columbia
4/24/2019
The opioid crisis continues to be one of the most serious public health issues in Canada's recent history.
-
Aurinia Pharmaceuticals to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
4/24/2019
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the “Company”) today announced that members of the management team will present a corporate overview at the 2019 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 30, 2019 at 8:30am PT (11:30am ET) in Toronto, Ontario.
-
Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors
4/24/2019
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), today announced that Phaedra Chrousos has joined Vanda's Board of Directors, effective April 23, 2019.
-
Mallinckrodt Completes Expansion of Operations and Manufacturing Facility for StrataGraft® Regenerative Skin Tissue in Madison, Wis.
4/24/2019
Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today celebrated the completion of its expanded operations and manufacturing facility for the investigational StrataGraft® regenerative skin tissue, in Madison, Wis.
-
McKesson Declares Quarterly Dividend April 24, 2019
4/24/2019
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of thirty-nine cents per share on Common Stock.
-
John Deeken, MD named President, Inova Schar Cancer Institute
4/24/2019
Inova, Northern Virginia's largest non-profit healthcare provider, announces that John Deeken, MD, has been named President of Inova Schar Cancer Institute.
-
GRYYT Reports Georgia Council on Substance Abuse Launches Statewide Billboard Campaign
4/24/2019
GCSA, a nonprofit organization dedicated to building and supporting community alliances to reduce the impact of addiction through education, advocacy and training, today launches a billboard campaign to visualize their efforts throughout the state of Georgia.
-
Electromed, Inc. Schedules Release of Third Quarter Fiscal 2019 Financial Results and Conference Call
4/24/2019
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2019 third quarter ended March 31, 2019 on Tuesday, May 7, 2019 after the close of the stock market.